KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer

Title
KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer
Authors
Keywords
-
Journal
Cancer Biomarkers
Volume 16, Issue 4, Pages 513-521
Publisher
IOS Press
Online
2016-04-20
DOI
10.3233/cbm-160592

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now